A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
NCT00002294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To compare the safety and effectiveness of fluconazole with that of placebo as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
Conditions
- Meningitis, Cryptococcal
- HIV Infections
Interventions
- DRUG
-
Fluconazole
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
NCT00002074 ·Status: COMPLETED ·Phase: NA
-
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
NCT00145249 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
NCT00002305 ·Status: COMPLETED ·Phase: NA
-
Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
NCT00002010 ·Status: COMPLETED ·Phase: NA
-
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
NCT00001017 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00002068 ·Status: COMPLETED ·Phase: NA
-
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
NCT00885703 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
NCT00000639 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
NCT01715922 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00002075 ·Status: COMPLETED ·Phase: NA
-
A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS
NCT00002282 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
NCT00002019 ·Status: COMPLETED ·Phase: NA
-
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
NCT00000708 ·Status: COMPLETED ·Phase: NA
-
A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems
NCT00002339 ·Status: COMPLETED ·Phase: PHASE3
-
Operational Research for Cryptococcal Antigen Screening
NCT01535469 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
NCT00012467 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy
NCT00002038 ·Status: COMPLETED ·Phase: NA
-
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
NCT00002399 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
NCT00002133 ·Status: COMPLETED ·Phase: NA
-
Clinical Effectiveness and Safety of Amphotericin B With Flucytosine-Fluconazole Therapy for Cryptococcal Meningitis
NCT04532463 ·Status: COMPLETED
-
A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
NCT00002341 ·Status: COMPLETED ·Phase: NA
-
Platform Trial For Cryptococcal Meningitis
NCT06666322 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency Syndrome
NCT00002112 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
NCT00000744 ·Status: COMPLETED ·Phase: NA